These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 23978105)

  • 1. Targeted gene deletion of prolyl hydroxylase domain protein 3 triggers angiogenesis and preserves cardiac function by stabilizing hypoxia inducible factor 1 alpha following myocardial infarction.
    Oriowo B; Thirunavukkarasu M; Selvaraju V; Adluri RS; Zhan L; Takeda K; Fong GH; Sanchez JA; Maulik N
    Curr Pharm Des; 2014; 20(9):1305-10. PubMed ID: 23978105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion of prolyl hydroxylase domain proteins (PHD1, PHD3) stabilizes hypoxia inducible factor-1 alpha, promotes neovascularization, and improves perfusion in a murine model of hind-limb ischemia.
    Rishi MT; Selvaraju V; Thirunavukkarasu M; Shaikh IA; Takeda K; Fong GH; Palesty JA; Sanchez JA; Maulik N
    Microvasc Res; 2015 Jan; 97():181-8. PubMed ID: 25446011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depletion of PHD3 protects heart from ischemia/reperfusion injury by inhibiting cardiomyocyte apoptosis.
    Xie L; Pi X; Wang Z; He J; Willis MS; Patterson C
    J Mol Cell Cardiol; 2015 Mar; 80():156-65. PubMed ID: 25633836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective Effect of Cardiomyocyte-Specific Prolyl-4-Hydroxylase 2 Inhibition on Ischemic Injury in a Mouse MI Model.
    Pradeep SR; Lim ST; Thirunavukkarasu M; Joshi M; Cernuda B; Palesty JA; Maulik N
    J Am Coll Surg; 2022 Aug; 235(2):240-254. PubMed ID: 35758926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disruption of hypoxia-inducible transcription factor-prolyl hydroxylase domain-1 (PHD-1-/-) attenuates ex vivo myocardial ischemia/reperfusion injury through hypoxia-inducible factor-1α transcription factor and its target genes in mice.
    Adluri RS; Thirunavukkarasu M; Dunna NR; Zhan L; Oriowo B; Takeda K; Sanchez JA; Otani H; Maulik G; Fong GH; Maulik N
    Antioxid Redox Signal; 2011 Oct; 15(7):1789-97. PubMed ID: 21083501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolyl 4-Hydroxylase Domain Protein 3 Overexpression Improved Obstructive Sleep Apnea-Induced Cardiac Perivascular Fibrosis Partially by Suppressing Endothelial-to-Mesenchymal Transition.
    Zhang GH; Yu FC; Li Y; Wei Q; Song SS; Zhou FP; Tong JY
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29051216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infarct size-limiting effect of epoxyeicosatrienoic acid analog EET-B is mediated by hypoxia-inducible factor-1α via downregulation of prolyl hydroxylase 3.
    Neckář J; Hsu A; Hye Khan MA; Gross GJ; Nithipatikom K; Cyprová M; Benák D; Hlaváčková M; Sotáková-Kašparová D; Falck JR; Sedmera D; Kolář F; Imig JD
    Am J Physiol Heart Circ Physiol; 2018 Nov; 315(5):H1148-H1158. PubMed ID: 30074840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simvastatin treatment inhibits hypoxia inducible factor 1-alpha-(HIF-1alpha)-prolyl-4-hydroxylase 3 (PHD-3) and increases angiogenesis after myocardial infarction in streptozotocin-induced diabetic rat.
    Thirunavukkarasu M; Selvaraju V; Dunna NR; Foye JL; Joshi M; Otani H; Maulik N
    Int J Cardiol; 2013 Oct; 168(3):2474-80. PubMed ID: 23590933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of prolyl hydroxylase domain proteins promotes therapeutic revascularization.
    Loinard C; Ginouvès A; Vilar J; Cochain C; Zouggari Y; Recalde A; Duriez M; Lévy BI; Pouysségur J; Berra E; Silvestre JS
    Circulation; 2009 Jul; 120(1):50-9. PubMed ID: 19546390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ang-1 gene therapy inhibits hypoxia-inducible factor-1alpha (HIF-1alpha)-prolyl-4-hydroxylase-2, stabilizes HIF-1alpha expression, and normalizes immature vasculature in db/db mice.
    Chen JX; Stinnett A
    Diabetes; 2008 Dec; 57(12):3335-43. PubMed ID: 18835934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIF-prolyl hydroxylases and cardiovascular diseases.
    Sen Banerjee S; Thirunavukkarasu M; Tipu Rishi M; Sanchez JA; Maulik N; Maulik G
    Toxicol Mech Methods; 2012 Jun; 22(5):347-58. PubMed ID: 22424133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletion of prolyl hydroxylase domain-containing enzyme 3 (phd3) in zebrafish facilitates hypoxia tolerance.
    Liao Q; Deng H; Wang Z; Yu G; Zhu C; Jia S; Liu W; Bai Y; Sun X; Chen X; Xiao W; Liu X
    J Biol Chem; 2023 Dec; 299(12):105420. PubMed ID: 37923141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morg1(+/-) heterozygous mice are protected from experimentally induced focal cerebral ischemia.
    Stahr A; Frahm C; Kretz A; Bondeva T; Witte OW; Wolf G
    Brain Res; 2012 Oct; 1482():22-31. PubMed ID: 22982595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of prolyl hydroxylase inhibitors on adipogenesis and hypoxia inducible factor 1 alpha levels under normoxic conditions.
    Floyd ZE; Kilroy G; Wu X; Gimble JM
    J Cell Biochem; 2007 Aug; 101(6):1545-57. PubMed ID: 17370314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PHD3 is a transcriptional coactivator of HIF-1α in nucleus pulposus cells independent of the PKM2-JMJD5 axis.
    Schoepflin ZR; Silagi ES; Shapiro IM; Risbud MV
    FASEB J; 2017 Sep; 31(9):3831-3847. PubMed ID: 28495754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II differentially regulates Morg1 expression in kidney cells.
    Bondeva T; Heinzig J; Franke S; Wolf G
    Am J Nephrol; 2012; 35(5):442-55. PubMed ID: 22555025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double knockdown of prolyl hydroxylase and factor-inhibiting hypoxia-inducible factor with nonviral minicircle gene therapy enhances stem cell mobilization and angiogenesis after myocardial infarction.
    Huang M; Nguyen P; Jia F; Hu S; Gong Y; de Almeida PE; Wang L; Nag D; Kay MA; Giaccia AJ; Robbins RC; Wu JC
    Circulation; 2011 Sep; 124(11 Suppl):S46-54. PubMed ID: 21911818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiomyocyte-Specific Transgenic Expression of Prolyl-4-Hydroxylase Domain 3 Impairs the Myocardial Response to Ischemia.
    Zieseniss A; Hesse AR; Jatho A; Krull S; Hölscher M; Vogel S; Katschinski DM
    Cell Physiol Biochem; 2015; 36(3):843-51. PubMed ID: 26044310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA methylation analysis of the HIF-1α prolyl hydroxylase domain genes PHD1, PHD2, PHD3 and the factor inhibiting HIF gene FIH in invasive breast carcinomas.
    Huang KT; Mikeska T; Dobrovic A; Fox SB
    Histopathology; 2010 Sep; 57(3):451-60. PubMed ID: 20727020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Endothelial PHD2 Suppresses Post-Ischemic Kidney Inflammation through Hypoxia-Inducible Factor-1.
    Rajendran G; Schonfeld MP; Tiwari R; Huang S; Torosyan R; Fields T; Park J; Susztak K; Kapitsinou PP
    J Am Soc Nephrol; 2020 Mar; 31(3):501-516. PubMed ID: 31996410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.